175 related articles for article (PubMed ID: 32876327)
1. Comparison of the characteristics of patients with invasive infections and noninvasive infections caused by Trichosporon asahii.
Kim J; Kim MJ; Chong YP; Kim SH; Choi SH; Lee SO; Woo JH; Kim YS; Jung J
Med Mycol; 2021 Mar; 59(3):296-300. PubMed ID: 32876327
[TBL] [Abstract][Full Text] [Related]
2. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
4. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
5. Differences of clinical characteristics and outcome in proven invasive Trichosporon infections caused by asahii and non-asahii species.
Lee EH; Choi MH; Lee KH; Song YG; Han SH
Mycoses; 2023 Nov; 66(11):992-1002. PubMed ID: 37515448
[TBL] [Abstract][Full Text] [Related]
6. [Nosocomial infection due to Trichosporon asahii in a critical burned patient].
Tamayo Lomas L; Domínguez-Gil González M; Martín Luengo AI; Eiros Bouza JM; Piqueras Pérez JM
Rev Iberoam Micol; 2015; 32(4):257-60. PubMed ID: 25579090
[TBL] [Abstract][Full Text] [Related]
7. Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia.
Cardenas-de la Garza JA; Ancer-Arellano J; Cuellar-Barboza A; Saenz-Ibarra B; Ocampo-Garza SS; Barboza-Quintana O; Gallardo-Rocha A; Vera-Cabrera L; Ocampo-Candiani J; Welsh O
J Dermatol; 2019 Apr; 46(4):e128-e129. PubMed ID: 30295013
[No Abstract] [Full Text] [Related]
8. [An overview on Trichosporon asahii and its infections].
Hazırolan G
Mikrobiyol Bul; 2012 Oct; 46(4):707-15. PubMed ID: 23188586
[TBL] [Abstract][Full Text] [Related]
9. Chemoport-related Fungemia Caused by Trichosporon asahii.
Raju DS; Sugunan A; Keechilattu P; Philip A; Reghu R
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e193-e194. PubMed ID: 30676435
[TBL] [Abstract][Full Text] [Related]
10. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
11. Catheter-related bloodstream infections caused by Trichosporon species.
Issarachaikul R; Lertwannawit O; Detporntewan P; Uaprasert N; Plongla R; Shuangshoti S; Chindamporn A; Suankratay C
Southeast Asian J Trop Med Public Health; 2014 Mar; 45(2):421-9. PubMed ID: 24968684
[TBL] [Abstract][Full Text] [Related]
12. Trichosporon asahii, sepsis, and secondary hemophagocytic lymphohistiocytosis in children with hematologic malignancy.
Karapinar DY; Karadaş N; Yazici P; Polat SH; Karapinar B
Pediatr Hematol Oncol; 2014 Apr; 31(3):282-4. PubMed ID: 24383917
[TBL] [Abstract][Full Text] [Related]
13. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
14. Endogenous Trichosporon Asahii Retinitis.
Parrozzani R; Marchione G; Midena G
Ophthalmology; 2022 Jan; 129(1):66. PubMed ID: 34930551
[No Abstract] [Full Text] [Related]
15. A rare case of urinary tract infection due to Trichosporon asahii in a diabetic patient.
Iken M; Belkouch A; Bellarj B; Naoui H; Boumhil L; El Bouti A; Jidane S; Belyamani L; Lmimouni B
Pan Afr Med J; 2015; 20():127. PubMed ID: 26097631
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Activity and Potential Action Mechanism of Allicin against Trichosporon asahii.
Yang X; Bai S; Wu J; Fan Y; Zou Y; Xia Z; Ao J; Chen T; Zhang M; Yang R
Microbiol Spectr; 2023 Jun; 11(3):e0090723. PubMed ID: 37199655
[TBL] [Abstract][Full Text] [Related]
17. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
18. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.
Padovan ACB; Rocha WPDS; Toti ACM; Freitas de Jesus DF; Chaves GM; Colombo AL
Fungal Genet Biol; 2019 Dec; 133():103267. PubMed ID: 31513917
[TBL] [Abstract][Full Text] [Related]
19. Possible Trichosporon asahii urinary tract infection in a critically ill COVID-19 patient.
Vianello M; Jesus DFF; Sampaio JM; de Oliveira GM; Lincopan N; Ishida K
Rev Iberoam Micol; 2022; 39(2):54-56. PubMed ID: 35788316
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole.
Sah R; Soin AS; Chawla S; Wadhwa T; Gupta N
Immun Inflamm Dis; 2019 Sep; 7(3):125-129. PubMed ID: 31006179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
